Press Releases

November 13, 2018

ProMIS Neurosciences Announces Third Quarter 2018 Results

November 6, 2018

ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease

October 31, 2018

ProMIS Neurosciences Identifies Novel Targets on Tau Protein Involved in the Development of Alzheimer’s Disease and Other Dementias

October 11, 2018

ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson’s Disease

September 17, 2018

ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference

September 13, 2018

ProMIS Neurosciences Appoints James Kupiec, MD as Chief Medical Officer

In the News

September 12, 2018

Global Business Report – Interview with Eugene Williams Executive Chairman, ProMIS

September 12, 2018

Stockhouse – The Key to Unlocking Alzheimer’s Treatment?

August 27, 2018

Alzheimer’s News Today – ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates

July 12, 2018

The ALS Research Forum – Update: Targeting TDP-43 in ALS

July 9, 2018

Investor’s Business Daily – TECHNOLOGY Why Hope Endures For An Alzheimer’s Treatment

June 21, 2018

Clinical Leader – ProMIS Trial Offers Hope For Alzheimer’s Patients

Presentations

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

July 31, 2018

AAIC White Paper 2018

July 31, 2018

AAIC Poster 2018

February 2, 2018

Hope For Alzheimer’s Disease

January 31, 2018

Eugene Williams, Executive Chairman presents at Noble Capital Markets’ Fourteenth Annual Investor Conference

Videos

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

March 14, 2018

Narrated Overview March 2018

February 15, 2018

Hope for Alzheimer’s

October 16, 2017

Presentation by ProMIS Chief Development Officer, Dr. Johanne Kaplan, on PMN310 Best in Class Product Profile

October 10, 2017

Narrated Overview October 2017